Autoimmunity in hepatitis C virus carriers: Involvement of ferritin and prolactin

Autoimmunity Reviews

Volumn 10, Issue 4, 2011, Pages 210-213

  Sousa, Gabriel M ^a   Oliveira, Rodrigo C ^a   Pereira, Mariana M ^a   Paraná, Raymundo ^a   Sousa Atta, Maria Luiza B ^a   Atta, Ajax M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Autoimmunity; Ferritin; Hepatitis C; Prolactin

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CRYOGLOBULIN; FERRITIN; IMMUNOGLOBULIN A ANTIBODY; PROLACTIN; RF ANTIBODY; SMOOTH MUSCLE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY PRODUCTION; AUTOIMMUNITY; CHEMOLUMINESCENCE; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERFERRITINEMIA; HYPERPROLACTINEMIA; MAJOR CLINICAL STUDY; MALE; PROLACTIN BLOOD LEVEL; REVIEW;

ADULT; AUTOANTIBODIES; AUTOIMMUNITY; CARRIER STATE; CRYOGLOBULINEMIA; FEMALE; FERRITINS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; HYPERPROLACTINEMIA; IRON METABOLISM DISORDERS; MALE; MIDDLE AGED; PROLACTIN;

EID: 79951856918     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.10.003     Document Type: Review

References (26)

1. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis 2008, 163:25.
2. Charles E.D., Dustin L.B. Hepatitis C virus-induced cryoglobulinemia. Kidney Int 2009, 76:818-824.
3. Ferri C., Antonelli A., Mascia M.T., Sebastiani M., Fallahi P., Ferrari D., et al. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis 2007, 39(Suppl 1):S13-S21.
4. Zignego A.L., Piluso A., Giannini C. HBV and HCV chronic infection: autoimmune manifestations and lymphoproliferation. Autoimmun Rev 2008, 8:107-111.
5. Ramos-Casals M., Muñoz S., Medina F., Jara L.J., Rosas J., Calvo-Alen J., et al. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry). J Rheumatol 2009, 36:1442-1448.
6. Plot L., Amital H. Infectious associations of Celiac disease. Autoimmun Rev 2009, 8:316-319.
7. Palazzi C., D'Angelo S., Olivieri I. Hepatitis C virus-related arthritis. Autoimmun Rev 2008, 8:48-51.
8. Ceribelli A., Cavazzana I., Cattaneo R., Franceschini F. Hepatitis C virus infection and primary Sjögren's syndrome: a clinical and serologic description of 9 patients. Autoimmun Rev 2008, 8:92-94.
9. Vera-Lastra O., Jara L.J., Espinoza L.R. Prolactin and autoimmunity. Autoimmun Rev 2002, 1:360-364.
10. De Bellis A., Bizzarro A., Pivonello R., Lombardi G., Bellastella A. Prolactin and autoimmunity. Pituitary 2005, 8:25-30.
11. Orbach H., Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. Autoimmun Rev 2007, 6:537-542.
12. Jara L.J., Benitez G., Medina G. Prolactin, dendritic cells, and systemic lupus erythematosus. Autoimmun Rev 2008, 7:251-255.
13. Lim M.K., Lee C.K., Ju Y.S., Cho Y.S., Lee M.S., Yoo B., et al. Serum ferritin as a serologic marker of activity in systemic lupus erythematosus. Rheumatol Int 2001, 20:89-93.
14. Zandman-Goddard G., Shoenfeld Y. Ferritin in autoimmune diseases. Autoimmun Rev 2007, 6:457-463.
15. Gray C.P., Arosio P., Hersey P. Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. Blood 2002, 9:3326-3334.
16. Wang W., Knovich M.A., Coffman L.G., Torti F.M., Torti S.V. Serum ferritin: past, present and future. Biochim Biophys Acta 2010, 1800:760-769.
17. Sansonno L., Tucci F.A., Sansonno S., Lauletta G., Troiani L., Sansonno D. B cells and HCV: an infection model of autoimmunity. Autoimmun Rev 2009, 9:93-94.
18. Toubi E., Gordon S., Kessel A., Rosner I., Rozenbaum M., Shoenfeld Y., et al. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. J Autoimmun 2006, 27:134-139.
19. Sène D., Limal N., Ghillani-Dalbin P., Saadoun D., Piette J.C., Cacoub P. Hepatitis C virus-associated B-cell proliferation-the role of serum B lymphocyte stimulator (BLyS/BAFF). Rheumatology (Oxford) 2007, 46:65-69.
20. De Vita S., Quartuccio L., Fabris M. Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation:targeting the infectious trigger, the autoimmune response, or both? Autoimmun Rev 2008, 8:95-99.
21. Atta A.M., Oliveira I.S., Sousa G.M., Paraná R., Atta M.L. Serum cytokine profile in hepatitis C virus carriers presenting cryoglobulinaemia and non-organ-specific autoantibodies. Microb Pathog 2010, 48:53-56.
22. Cancro M.P., D'Cruz D.P., Khamashta M.A. The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus. J Clin Invest 2009, 119:1066-1073.
23. Migita K., Abiru S., Maeda Y., Nakamura M., Komori A., Ito M., et al. Elevated serum BAFF levels in patients with autoimmune hepatitis. Hum Immunol 2007, 68:586-591.
24. Jara L.J., Medina G., Saavedra M.A., Vera-Lastra O., Navarro C. Prolactin and autoimmunity. Clin Rev Allerg Immunol 2009, 10.1007/s12016-009-8185-3.
25. Gregorio G.V., Choudhuri K., Ma Y., Pensati P., Iorio R., Grant P., et al. Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clin Exp Immunol 2003, 133:404-413.
26. Shan Y., Lambrecht R.W., Bonkovsky H.L. Association of hepatitis C virus infection with serum iron status: analysis of data from the Third National Health and Nutrition Examination Survey. CID 2005, 40:834-841.